Acute Effects of 2C-E in Humans: An Observational Study
Open Access
- 18 March 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11, 233
- https://doi.org/10.3389/fphar.2020.00233
Abstract
2,5-Dimethoxy-4-ethylphenethylamine (2C-E) is psychedelic phenylethylamine, with a chemical structure similar to mescaline, used as new psychoactive substance (NPS). It inhibits norepinephrine and serotonin uptake and, more relevant, acts as a partial agonist of the serotonin 2A (5-HT2A), 2B (5-HT2B), and (5-HT2C) receptors. Consumers have reported that 2C-E induces mild-moderate psychedelic effects, but its pharmacology in humans, including pharmacological effects and pharmacokinetics, have not yet studied. To assess the acute effects of 2C-E on physiological and subjective effects and evaluate its pharmacokinetics, an observational study was carried-out. Ten recreational users of psychedelics self-administered a single oral dose of 2C-E (6.5, 8, 10, 15, or 25 mg). Blood pressure and heart rate were evaluated at baseline, 2, 4, and 6 h post-administration. Three rating scales were administered to evaluate subjective effects: a set of Visual Analog Scales (VAS), the 49-item short form version of the Addiction Research Centre Inventory (ARCI), and the Evaluation of the Subjective Effects of Substances with Abuse Potential (VESSPA-SSE) at baseline, 2, 4, and 6 h after self-administration. To assess 2C-E concentrations oral fluid (saliva) was collected during 6 h. 2C-E induced primarily alterations in perceptions, hallucinations, and euphoric-mood. Saliva maximal concentrations were achieved 2 h after self-administration. Administration of oral 2C-E at recreational doses produces a group of psychedelic-like effects such to 2C-B and other serotonin-acting drugs.Funding Information
- Instituto de Salud Carlos III (FISPI17/01962, RD16/0017/003, RD16/0017/0010, JR16/00020)
- Directorate-General for Justice and Consumers (HOME/2014/JDRU/AG/DRUG/7082)
This publication has 38 references indexed in Scilit:
- Acute Effects of Lysergic Acid Diethylamide in Healthy SubjectsBiological Psychiatry, 2015
- Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.Psychopharmacology, 2013
- Consumption of new psychoactive substances in a Spanish sample of research chemical usersHuman Psychopharmacology: Clinical and Experimental, 2013
- 2C or Not 2C: Phenethylamine Designer Drug ReviewJournal of Medical Toxicology, 2013
- 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effectsJournal of Psychopharmacology, 2012
- Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorumDrug and Alcohol Dependence, 2011
- The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brainEuropean Journal of Pharmacology, 2007
- Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-β-phenethylamine (2C-B) in rat urine using gas chromatography–mass spectrometryJournal of Chromatography B, 2007
- Effects of the South American Psychoactive Beverage Ayahuasca on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low-Resolution Electromagnetic TomographyNeuropsychobiology, 2004
- Spanish version of the 49-item short form of the Addiction Research Center Inventory (ARCI)Drug and Alcohol Dependence, 1994